Acute Myeloid Leukemia
📧 Sign up to get email alerts when something new happens for Acute Myeloid Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-07-08Clinical Trial Update: Wilm's Tumor 1 (WT1) Peptide Vaccine for High Risk Hematologic Malignancy [Phase 2]
Phase 2 trial of WT1 peptide vaccine in high-risk hematologic malignancies (myelodysplastic syndrome, acute myeloid leukemia, and chronic my…
-
CLINICAL_TRIALS trial_result · 2014-07-04Clinical Trial Update: Low Dose IL-2, Hematopoietic Stem Cell Transplantation, IL2 for GVHD [Phase 2]
Phase 2 trial update evaluating low-dose interleukin-2 in patients undergoing allogeneic hematopoietic stem cell transplantation to address …
-
CLINICAL_TRIALS trial_result · 2014-06-30Clinical Trial Update: Maintenance Azacitidine in Elderly Patients With Acute Myeloid Leukemia (AML) in CR After Induction Chemotherapy [Phase 2]
Phase 2 trial evaluating maintenance azacitidine in elderly patients with acute myeloid leukemia who achieved complete remission after induc…
-
CLINICAL_TRIALS trial_result · 2014-06-26Clinical Trial Update: Metabolism Des LAM
Clinical trial update for Metabolism Des LAM. Acute Myeloid Leukemia is among the conditions listed for the study, and the current trial sta…
-
CLINICAL_TRIALS trial_result · 2014-06-17Clinical Trial Update: Vorinostat With or Without Isotretinoin in Treating Young Patients With Recurrent or Refractory Solid Tumors, Lymphoma, or Leukemia [Phase 1]
Phase 1 study evaluating vorinostat with or without isotretinoin in pediatric patients with recurrent or refractory solid tumors, lymphoma, …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2014-06-11Clinical Trial Update: A Trial to Establish the Feasibility of Combining Either the Tyrosine Kinase Inhibitor AC220,CXCR4 Inhibitor Plerixafor or HSP90 Inhibitor Ganetespib With Chemotherapy in Older Patients With Acute Myeloid Leukaemia and High Risk Myelodysplastic Syndrome. [Phase 1, Phase 2]
This update notes the completion of a Phase 1/2 clinical trial evaluating the feasibility of combining three agents (Quizartinib, Plerixafor…
-
CLINICAL_TRIALS trial_result · 2014-05-26Clinical Trial Update: Tipifarnib and Etoposide in Treating Older Patients With Newly Diagnosed, Previously Untreated Acute Myeloid Leukemia [Phase 2]
Phase 2 trial assessing tipifarnib plus etoposide in older adults with newly diagnosed, untreated acute myeloid leukemia. The study is compl…
-
CLINICAL_TRIALS trial_result · 2014-05-19Clinical Trial Update: Total-Body Irradiation With or Without Fludarabine Phosphate Followed By Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer [Phase 3]
Phase 3 trial evaluating total-body irradiation with or without fludarabine phosphate followed by donor stem cell transplant in hematologic …
-
CLINICAL_TRIALS trial_result · 2014-05-16Clinical Trial Update: Phase I Trial to Investigate Cafusertib Hydrochloride in Combination With Low Dose Cytarabine in Chinese Patients With Acute Myeloid Leukaemia (AML) [Phase 1]
A Phase I clinical trial in Chinese patients with acute myeloid leukemia evaluating cafusertib hydrochloride in combination with low-dose cy…
-
CLINICAL_TRIALS trial_result · 2014-05-16Clinical Trial Update: BI 2536 Infusional Treatment in Patients Over 60 Years of Age With Refractory or Relapsed Acute Myeloid Leukaemia [Phase 2]
Phase 2 trial of BI 2536 infusional treatment in patients over 60 with refractory or relapsed acute myeloid leukemia has completed.
-
CLINICAL_TRIALS trial_result · 2014-05-08Clinical Trial Update: Wilm's Tumor 1 Protein Vaccine to Treat Cancers of the Blood [Phase 1, Phase 2]
Phase 1/2 trial evaluating Wilms' Tumor 1 protein vaccine for blood cancers has completed. Results were posted on 2014-05-08.
-
CLINICAL_TRIALS trial_result · 2014-05-06Clinical Trial Update: Induction, Consolidation and Intensification Therapy for Patients Younger Than 66 Years With Previously Untreated CD33 Positive Acute Myeloid Leukemia (AML) [Phase 2, Phase 3]
A completed Phase 2/3 clinical trial evaluating induction, consolidation, and intensification therapy for patients younger than 66 with prev…
-
CLINICAL_TRIALS research · 2014-05-06Clinical Trial Update: Rapid Profiling of Bone Marrow, at Presentation and After 5 Days of Induction Therapy
This clinical trial update covers rapid profiling of bone marrow at presentation and after five days of induction therapy in acute myeloid l…
-
CLINICAL_TRIALS trial_result · 2014-05-02Clinical Trial Update: Cyclophosphamide Plus Topotecan in Treating Patients With Refractory or Relapsed Acute Myelogenous Leukemia [Phase 2]
This document reports the completion of a Phase 2 clinical trial evaluating cyclophosphamide plus topotecan in patients with refractory or r…
-
CLINICAL_TRIALS trial_result · 2014-05-01Clinical Trial Update: Study of Iressa in Patients With Relapsed or Refractory Acute Myelogenous Leukemia [Phase 2]
This is a completed Phase 2 study of Iressa (gefitinib) in patients with relapsed or refractory acute myeloid leukemia. The trial status is …
-
CLINICAL_TRIALS trial_result · 2014-05-01Clinical Trial Update: Obatoclax Mesylate, Vincristine Sulfate, Doxorubicin Hydrochloride, and Dexrazoxane Hydrochloride in Treating Young Patients With Relapsed or Refractory Solid Tumors, Lymphoma, or Leukemia [Phase 1]
Phase 1 trial evaluating obatoclax mesylate in combination with vincristine, doxorubicin, and dexrazoxane in pediatric patients with relapse…
-
CLINICAL_TRIALS trial_result · 2014-04-30Clinical Trial Update: Natural Killer Index From Hematopoietic Stem Cell Graft [NA]
Clinical trial update on the natural killer index derived from hematopoietic stem cell graft. The study is listed as completed and includes …
-
CLINICAL_TRIALS trial_result · 2014-04-29Clinical Trial Update: MK2206 in Treating Younger Patients With Recurrent or Refractory Solid Tumors or Leukemia [Phase 1]
Phase 1 study of MK-2206 in pediatric patients with recurrent or refractory solid tumors or leukemias has completed.
-
CLINICAL_TRIALS trial_result · 2014-04-24Clinical Trial Update: Pilot Study of Expanded, Donor Natural Killer Cell Infusions for Refractory Non-B Lineage Hematologic Malignancies and Solid Tumors [Phase 1]
Phase 1 pilot study evaluating donor-derived natural killer cell infusions for refractory non-B lineage hematologic cancers and solid tumors…
-
CLINICAL_TRIALS trial_result · 2014-04-14Clinical Trial Update: Study to Assess Dasatinib in Patients With Core Binding Factors Acute Myelogenous Leukemia [Phase 2]
A Phase 2 clinical trial evaluating dasatinib in patients with core-binding factor acute myeloid leukemia has completed.
-
CLINICAL_TRIALS trial_result · 2014-04-07Clinical Trial Update: 3 Anthracyclines, 2 Types of Consolidation With Different ARA-C Doses and Maintenance in Adult Acute Myeloid Leukemia [Phase 4]
Phase 4 clinical trial evaluating three anthracyclines with two consolidation strategies using different cytarabine (ARA-C) doses and mainte…
-
CLINICAL_TRIALS trial_result · 2014-04-07Clinical Trial Update: Clofarabine and Low-dose Cytarabine Followed by Consolidation Therapy in AML Patients Age Greater Than or Equal to 60 Years [Phase 2]
A Phase 2 study of Clofarabine and low-dose Cytarabine followed by consolidation in patients with acute myeloid leukemia aged 60 and older h…
-
CLINICAL_TRIALS withdrawal · 2014-04-07Clinical Trial Update: LENA-LMA-5:Lenalidomide in Acute Myeloid Leukemia (AML) [Phase 4]
A Phase 4 clinical trial (LENA-LMA-5) evaluating lenalidomide in acute myeloid leukemia has been terminated.
-
CLINICAL_TRIALS trial_result · 2014-04-07Clinical Trial Update: AMD3100 for Sensitizing in Allogeneic Blood or Marrow Transplant for Chemotherapy Resistant Pediatric Acute Leukemia [Phase 1]
Phase 1 study of AMD3100 (plerixafor) as a sensitizing agent in allogeneic blood or marrow transplant for chemotherapy-resistant pediatric a…
-
CLINICAL_TRIALS trial_result · 2014-04-02Clinical Trial Update: Palifermin in Preventing Chronic Graft-Versus-Host Disease in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic Cancer [NA]
This clinical-trial update reports completion and results posting for palifermin used to prevent chronic graft-versus-host disease in patien…